Marijuana and CBD in Switzerland: Regulations 2026 (FAQ)

Switzerland punishes consumption with a fine, and products below 1 percent are not subject to narcotics law. We check the position of the health authority.

Switzerland has two numbers worth knowing before traveling, and both operate differently than in the EU. The first is 10 grams for personal use, and the second is a material threshold of 1 percent active substance content.

The second is ten times higher than the typical EU threshold, and it determines the shape of the local cannabis product market. Below is what follows from the position of the Swiss health authority and the list of substances.

Possession illegal, but up to 10 grams without criminal liability
Consumption administrative fine, not a conviction
Material threshold 1 percent active substance content
Below threshold product outside the narcotics law
Medical program since 2022 without the authority’s permission
HHC covered by name and by the general clause
Comparison with the EU threshold ten times higher than the EU’s 0.2 percent

Legal status checked in September 2026 on the Swiss health authority’s website and in the list of substances. This is a description of regulations, not legal advice.

Is possession of marijuana in Switzerland punishable?

It is illegal, but consumption is punished with an administrative fine, not a conviction, and this difference is practically the most important. The boundary is set by the content of the active substance, not the product name or its intended use. The outcome of the analysis determines, not the seller’s declaration.

A product with less than 1 percent content is not subject to the narcotics law at all. It falls outside this entire regime, not just benefiting from milder treatment within it.

A product with 1 percent or more content is a controlled substance, with all the consequences that entails. This one number thus divides the market into two parts subject to completely different regulations.

There is a separate quantity threshold for users. Possession of up to 10 grams for personal use does not incur criminal liability, although it does not make the act legal in the sense of the law.

Switzerland thus combines a high material threshold with a low response to minor possession. How it compares to its neighbors is shown in our map of marijuana legality.

It is worth remembering that both of these limits must be known simultaneously. The first refers to the material, the second to the quantity, and meeting one does not exempt from checking the other.

How much marijuana is allowed in Switzerland?

There are two numbers describing two completely different things, so confusing them leads to false conclusions. The first is 10 grams for personal use, and the second is a material threshold of 1 percent active substance content. Both are stated in the same position of the health authority.

The first concerns the amount a person has with them. Possession of up to 10 grams for personal use does not incur criminal liability, which is a threshold comparable to solutions in several EU countries.

The second concerns the material itself and is much more interesting. Below 1 percent, the product is outside the narcotics law, so it does not count towards any quantity threshold because it is not a controlled substance at all.

This is the highest threshold of its kind in Europe, and the difference from the EU is tenfold. EU regulations for hemp operate with values around two or three tenths of a percent.

For the buyer, this means that the same product can have a completely different status in Switzerland and Poland. The declaration on the packaging determines, not what the manufacturer called the product.

What are the consequences of exceeding the threshold in Switzerland?

For mere consumption, an administrative fine is imposed, not criminal proceedings. The Swiss health authority states this directly and unequivocally: those who consume cannabis may receive an administrative fine, and that is where the description ends. The response thus ends at the fine stage, without court involvement.

Possession of up to 10 grams for personal use is not punishable at all. These are two different situations, and it is worth separating them: consumption ends with a fine, while possession within the threshold does not incur liability.

The administrative fine is a separate institution from the fine imposed in proceedings. It is not associated with a conviction or with the record that a conviction carries, so its effects are limited to the amount itself.

Above the described threshold, the usual provisions of the narcotics law apply. However, the material we have does not describe those ranges, so we do not provide them.

The practical conclusion is that the Swiss response to minor possession is one of the mildest in this comparison. However, this does not mean legality, as the act remains in the law.

Does Switzerland have a medical marijuana program?

The program is operational, and since August 2022, it is much simpler than before, as a doctor can prescribe a cannabis medication without the health authority’s permission. Previously, each such prescription required a separate approval, which was the main barrier to access. The barrier that was removed was procedural, not substantive.

The amendment granted cannabinoid medications for therapeutic use a status of limited market approval. This is a change in legal category, not just a simplification of the form.

Responsibility for treatment now rests with the prescribing doctor. The authority no longer assesses the justification in a specific case, so the decision and its consequences remain with the therapist.

Indications include chronic pain in cancer and multiple sclerosis. The material we work with does not provide a closed list, so we do not present it as complete.

For a patient from Poland, the practical conclusion is that the Swiss path is shorter than in most countries in this cluster. However, the conditions for a person from outside the country are not described in this material.

In comparison, in most countries in this cluster, each prescription of a cannabis preparation requires separate approval from the authority or belongs to a narrow group of specialists. Switzerland has removed both of these restrictions at once.

What is the status of CBD in Switzerland?

Cannabis products with less than 1 percent active substance content are not subject to the narcotics law. This is the same threshold that sets the boundary of legality for dried cannabis, so the Swiss system is based on one number instead of two. The rest of the system is built around this one value.

The effect is far-reaching and explains the appearance of the local market. A product below the threshold is not a controlled substance in any way, so its trade is subject to ordinary product regulations, not drug law.

The margin is ten times wider than the EU’s. Switzerland allows a full percent where EU law stops at a fraction, so the same dried cannabis can be two different things on either side of the border.

This is precisely why Swiss cannabis products differ in potency from those sold in the EU. The difference does not arise from different technology, but from a different legal boundary.

For the traveler, the conclusion is cautious and works the other way. A product legally purchased in Switzerland may exceed the threshold applicable in the destination country, so transport across the border requires separate checking.

Switzerland has caught this substance twice, and this is a unique solution in this comparison. By name, it stands in the list of raw materials and products with presumed effects similar to narcotics, meaning it is in a category separate from ordinary drugs. Both paths operate in parallel and independently of each other.

However, there is a separate entry for cannabinoids, and that is the proper general clause. It covers any substance structurally derived from a specific chemical skeleton, substituted in three specified positions by any alkyl groups.

The most important phrase in this clause is one. It covers substances regardless of the degree of hydrogenation of the non-aromatic ring, which closes the path that the market opened in other countries.

A new derivative does not require addition to the list because it is covered from the outset. Changing the molecule that the market responded with to subsequent bans does not help here.

The clause has an exception formulated directly and is sometimes read in the opposite way to how it sounds. Industrial and scientific use is excluded from control, while private use is not. We describe this more broadly in our post about whether HHC is legal and safe.

What does Swiss law say about cannabis possession?

Possession of up to 10 grams for personal use is not punishable, but smoking itself is. Article 19b paragraph 1 of the Federal Act on Narcotics and Psychotropic Substances (Betäubungsmittelgesetz, BetmG) states that anyone preparing a small amount of a narcotic for personal use is not subject to punishment. Paragraph 2 adds that a small amount is 10 grams of cannabis.

This paragraph was added by the amendment of September 28, 2012, which came into force on October 1, 2013. The year 2011, repeated in Polish studies regarding this provision, is a mistake: it refers to another change, that of the 1 percent THC threshold.

Consumption is a separate matter. Article 19a of the BetmG still penalizes it, and Article 28b introduces an administrative procedure for adults: an administrative fine of 100 francs for a single act of consumption, provided the threshold of 10 grams is not exceeded. The fine thus covers the act of smoking, not the mere fact of carrying a supply with oneself. This distinction is practically significant, as the police penalize behavior, not pocket content.

Above 10 grams and in cases of trade, cultivation, and trafficking, Article 19 of the BetmG and ordinary criminal proceedings apply. The administrative procedure does not cover minors, so the response is stricter for them.

Action Status in Switzerland in 2026 Basis
Possession of up to 10 g for personal use not punishable art. 19b BetmG
Consumption by an adult administrative fine of 100 CHF art. 19a and art. 28b BetmG
Possession above 10 g, trade, cultivation offense art. 19 BetmG
Sale in research pilot legal for registered participants art. 8a BetmG
Cannabis below 1 percent THC outside the narcotics law narcotics regulation
Cannabis on prescription legal since August 1, 2022 amendment to the BetmG from 2021

What are Swiss cannabis sales pilot programs?

These are scientific studies with participant registration, not an open market. The basis is Article 8a of the BetmG, which has been in effect since May 15, 2021, and itself has been limited in time to ten years. The Federal Office of Public Health approves individual programs and supervises their course.

There are eight approved programs. WeedCare operates in Basel-City, ZüriCan in Zurich, and Cannabis Research Zürich in the canton of Zurich. The SCRIPT program covers Bern, Biel, and Lucerne. Additionally, there are Cann-L in Lausanne, La Cannabinothèque in Vernier near Geneva, Grashaus Projects in Liestal and Allschwil, as well as CanLeg in the canton of St. Gallen.

A participant must be of legal age, reside in the canton covered by the study, and declare that they already use cannabis. Products undergo laboratory testing, sales occur at designated points, and participants regularly fill out surveys. A tourist will not be able to buy anything there, as registration in the study is a condition for purchase. How the same questions were resolved on the other side of the border is described in our post about regulations in Austria and Alpine countries.

Separately, a legislative process is underway regarding the Cannabis Products Act (Cannabisproduktegesetz). The project was prepared by the National Council committee and adopted in mid-February 2025, and the consultation report was published by the authority on May 8, 2026. The authority does not provide a date for the law’s entry into force, and such a date does not exist today.

Why does the Swiss threshold of 1 percent THC not work in Poland?

Because these are two separate regulations with different values and different subjects. The Swiss principle is formulated by the Federal Office of Public Health in one sentence: cannabis with THC content below 1 percent is not subject to the narcotics law. The threshold was introduced by the amendment of the narcotics regulation from 2011 and has been in effect ever since.

Poland counts differently. The basis is Article 4 point 5 of the Act on Counteracting Drug Addiction in the consolidated text Dz.U. 2023 poz. 1939, as amended by the Act of March 24, 2022 (Dz.U. 2022 poz. 763). The value is 0.3 percent calculated on dry mass, measured in flowering and fruiting tops, rounded to one decimal place.

There are more differences than one. The Polish regulation sums two compounds, delta-9-THC and tetrahydrocannabinolic acid, while the Swiss one refers only to THC, so the same sample may be counted differently on both sides of the border.

The EU threshold is also currently 0.3 percent, based on Article 4 paragraph 4 of Regulation (EU) 2021/2115, applicable since January 1, 2023. The previous 0.2 percent came from Regulation 1307/2013, repealed on the same date. The Polish threshold does not arise from EU regulation but numerically corresponds to it.

The conclusion for the traveler is simple. Dried cannabis with 0.8 percent THC, legally sold in Basel, falls above the threshold of Article 4 point 5 in Poland and is cannabis other than fiber hemp. The conditions for the legal cultivation of fiber hemp in the country are described in a separate post.

Who in Switzerland can get cannabis on prescription?

Since August 1, 2022, any doctor can prescribe it without prior approval from the authority. On that day, the amendment to the BetmG came into force, which lifted the ban on using cannabis for medical purposes. The Federal Office of Public Health describes the effect directly: the doctor prescribes a cannabis preparation without the authority’s permission, and the responsibility for treatment rests solely with them.

Previously, the patient needed special permission from the authority, issued for a maximum of twelve months and requiring a new application after expiration. The procedure was narrow, and that is why the change in 2022 was felt by patients.

Two cannabis medications are registered by Swissmedic: Sativex, approved in Switzerland since 2013 as an adjunct therapy for moderate to severe spasticity in multiple sclerosis, and Epidyolex. Other preparations are made as magistral medicines, prepared in pharmacies based on prescriptions issued for specific patients. Typical uses indicated by the authority include chronic pain in cancer patients and symptoms of multiple sclerosis.

The production and trade of cannabis medications are subject to approval and control by Swissmedic. The use of cannabis outside of medicine remains prohibited in Switzerland, and pilot programs are a statutory exception to this rule, not its repeal.

Frequently asked questions

How much marijuana can I have in Switzerland?

Possession of up to 10 grams for personal use does not incur criminal liability. However, this does not make the act legal, as the prohibition remains in the narcotics law.

What are the consequences in Switzerland for smoking marijuana?

An administrative fine. The health authority states this directly: those who consume cannabis may receive an administrative fine. This is a separate institution from the fine imposed in proceedings and is not associated with a conviction.

What is the THC content threshold in Switzerland?

One percent. A product below this value is not subject to the narcotics law at all, while anything above it is a controlled substance. This is the highest threshold of its kind in Europe.

Can I bring Swiss CBD to Poland?

The Swiss margin is ten times wider than the EU’s, so a product legally purchased there may exceed the threshold applicable in the destination country. Transport requires separate checking.

Does a doctor in Switzerland need approval from the authority for cannabis medication?

Since August 2022, no. The amendment granted cannabinoid medications a status of limited market approval, and the responsibility for treatment rests with the prescribing doctor.

No. The substance is listed by name, and it is also covered by a general clause that operates independently of the degree of hydrogenation. Only industrial and scientific use is excluded from control.

Sources

Act or document Address Checked Degree of proof
Betäubungsmittelgesetz (BetmG), art. 8a; position of the Federal Office of Public Health (BAG) bag.admin.ch 2026-09-04 position of the authority
Betäubungsmittelgesetz (BetmG), art. 8a; position of BAG bag.admin.ch 2026-09-04 position of the authority
Amendment to the Betäubungsmittelgesetz effective since August 2022; position of BAG bag.admin.ch 2026-09-04 position of the authority
Betäubungsmittelgesetz (BetmG); position of BAG bag.admin.ch 2026-09-04 position of the authority
Regulation of the Federal Department of Home Affairs of May 30, 2011, on the lists of narcotics, psychotropic substances, precursors, and auxiliary chemicals (BetmVV-EDI), SR 812.121.11, list e to art. 2 paragraph 2, items 301 and 303; list as amended by the EDI regulation of January 16, 2026, effective from March 13, 2026, at 10:00 fedlex.admin.ch 2026-09-05 text of the legal act

This article is for informational and educational purposes and does not constitute legal advice. The legal status described in the article is valid as of the publication date: cannabis regulations may change. Before making decisions, consult a lawyer or current legal acts.

Author: Michał Waluk

Podziel się:
Zaufanie
Dowiedz się więcej o nas
Darmowa wysyłka
Od 49PLN - paczkomatem
Łatwy kontakt
Masz pytania? Skontaktuj się z nami.
Lojalność
Jedyny taki program - zbieraj buchy

Strona tylko dla osób pełnoletnich.

Czy masz ukończone 18 lat?

Buch z Tobą